• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Autoimmune Disease Diagnostics Market Size

    ID: MRFR/HC/5252-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Autoimmune Disease Diagnostics Market Research Report By Test Type (Serological Tests, Molecular Diagnostics, Imaging Tests, Biopsies), By Disease Type (Rheumatoid Arthritis, Lupus, Multiple Sclerosis, Type 1 Diabetes, Thyroid Disorders), By End-user (Hospitals, Diagnostic Laboratories, Research Institutes), By Product Type (Reagents, Instrumentations, Software), and By Regional (North America,...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Autoimmune Disease Diagnostics Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Autoimmune Disease Diagnostics Size

    Autoimmune Disease Diagnostics Market Growth Projections and Opportunities

    One major factor propelling the growth of the diagnostics industry is the increase in the prevalence of autoimmune illnesses. The increasing prevalence of autoimmune disorders necessitates the use of efficient diagnostic tools due to factors such as changing lifestyles, environmental factors, and genetic predisposition. Autoimmune illness diagnosis is becoming more and more popular as a result of efforts made by support groups and medical associations to educate the public as well as medical professionals. There is growing interest in autoimmune illness diagnostics that can conclusively identify the objective antibodies or biomarkers associated with various autoimmune conditions, as medical service providers and patients search for more precise and explicit demonstration tactics. This factor has a big role in combining market components. Since the elderly population is more vulnerable to these conditions, the maturing population contributes to the surge in autoimmune disorders. This change in the segment addresses the need for autoimmune disease diagnosis, since early detection of the illness becomes increasingly important for convincing executives with more established illnesses. The use of medical services and financial stability have an impact on the availability of diagnostics for autoimmune diseases. The affordability and accessibility of modern facilities demonstrative advances directly impact market entry and a location's financial performance. The market for autoimmune disease diagnostics is directly impacted by the growing trend toward reason underlying care testing, which is being driven by the need for quick and dispersed symptomatic arrangements. POCT is a desirable option for medical care providers as well as patients because it provides flexibility and faster outcomes. The growing focus on personalized medicine, appropriate treatment approaches considering unique patient characteristics, extends beyond diagnostics. Diagnostics for autoimmune diseases, which enable targeted and individualized treatments, are starting to move forward and establish market trends.

    Autoimmune Disease Diagnostics Market Size Graph

    Market Summary

    As per Market Research Future Analysis, the Autoimmune Disease Diagnostics Market was valued at 5.58 USD Billion in 2024 and is projected to reach 11.41 USD Billion by 2035, growing at a CAGR of 6.72% from 2025 to 2035. The market is driven by the increasing prevalence of autoimmune diseases, technological advancements in diagnostic tools, and heightened awareness among patients and healthcare providers.

    Key Market Trends & Highlights

    Key trends driving the Autoimmune Disease Diagnostics Market include technological innovations and rising disease awareness.

    • The market is expected to grow from 6.72 USD Billion in 2024 to 12.3 USD Billion by 2035. Serological Tests are projected to rise from 2.68 USD Billion in 2024 to 4.8 USD Billion by 2035. Molecular Diagnostics are anticipated to grow from 1.85 USD Billion in 2024 to 3.4 USD Billion by 2035. North America is expected to dominate the market with a valuation of 2.8 USD Billion in 2024.

    Market Size & Forecast

    2024 Market Size USD 5.58 Billion
    2035 Market Size USD 11.41 Billion
    CAGR (2025-2035) 6.72%
    Largest Regional Market Share in 2024 North America.

    Major Players

    <p>Key players include Genentech, Abbott Laboratories, Hologic, BD, Quest Diagnostics, Thermo Fisher Scientific, ImmunoPrecise Antibodies, ArcherDX, LabCorp, Roche Diagnostics, Mayo Clinic Laboratories, Eurofins Scientific, BioRad Laboratories, Cepheid, Siemens Healthineers.</p>

    Market Trends

    One significant trend in the global market for autoimmune disease diagnostics is the growing emphasis on cutting-edge diagnostic methods like next-generation sequencing and biomarker discovery. These methods improve the precision of autoimmune disease diagnosis, which increases demand in medical facilities.

    Another important market driver is the rising incidence of autoimmune illnesses around the world. According to the World Health Organization, millions of people suffer from autoimmune disorders, and their prevalence is increasing. This underscores the pressing need for efficient diagnostic tools. There are prospects to investigate in this industry due to the growth of customized medicine.

    Additionally, recent patterns show that pharmaceutical companies and biotech companies have significantly increased their investment in autoimmune disease research and development. This tendency is crucial for fostering innovation and producing new, more dependable, and more affordable diagnostic instruments and tests.

    Additionally, industry-academia cooperation are become more frequent, which promotes the creation of novel diagnostic tools. Overall, the future of diagnostics in this crucial field of healthcare is being shaped by the convergence of cutting-edge technology, rising autoimmune disease prevalence, and the expansion of point-of-care and tailored testing.

     

    <p>The increasing prevalence of autoimmune diseases, coupled with advancements in diagnostic technologies, suggests a burgeoning demand for innovative and accurate diagnostic solutions in the global market.</p>

    U.S. National Institutes of Health (NIH)

    Autoimmune Disease Diagnostics Market Market Drivers

    Increased Awareness and Education

    Growing awareness regarding autoimmune diseases among healthcare professionals and the general public is driving the Global Autoimmune Disease Diagnostics Market Industry. Educational initiatives and campaigns aimed at highlighting the symptoms and implications of autoimmune disorders have led to earlier diagnosis and treatment. This heightened awareness is reflected in increased patient consultations and testing rates. As a result, the market is poised for growth, with projections indicating it could reach 12.3 USD Billion by 2035. The emphasis on education and awareness is likely to foster a more proactive approach to managing autoimmune diseases, thereby enhancing the demand for diagnostic services.

    Government Initiatives and Funding

    Government initiatives aimed at improving healthcare infrastructure and funding for autoimmune disease research are pivotal to the Global Autoimmune Disease Diagnostics Market Industry. Various countries are investing in research programs and public health campaigns to better understand autoimmune disorders and develop effective diagnostic tools. For instance, funding from national health organizations supports studies that explore the etiology and progression of these diseases. Such initiatives not only enhance research capabilities but also promote the development of innovative diagnostic solutions. As the market continues to evolve, government support is likely to remain a critical factor in driving advancements in autoimmune disease diagnostics.

    Growing Demand for Personalized Medicine

    The shift towards personalized medicine is influencing the Global Autoimmune Disease Diagnostics Market Industry significantly. Tailoring treatment plans based on individual patient profiles, including genetic and biomarker information, enhances therapeutic efficacy. This trend is particularly relevant in autoimmune diseases, where treatment responses can vary widely among patients. The demand for personalized diagnostics is expected to rise as healthcare providers seek to optimize treatment outcomes. As the market evolves, the integration of personalized medicine into diagnostic practices is likely to drive growth, aligning with the projected market expansion to 12.3 USD Billion by 2035.

    Rising Prevalence of Autoimmune Diseases

    The increasing incidence of autoimmune diseases globally is a primary driver for the Global Autoimmune Disease Diagnostics Market Industry. Conditions such as rheumatoid arthritis, lupus, and multiple sclerosis are becoming more prevalent, affecting millions worldwide. For instance, the prevalence of rheumatoid arthritis is estimated to be around 0.5 to 1 percent of the global population. This rise in cases necessitates advanced diagnostic tools and techniques, propelling market growth. As the market is projected to reach 6.72 USD Billion in 2024, the demand for accurate diagnostics is likely to escalate, influencing healthcare strategies and resource allocation.

    Technological Advancements in Diagnostic Tools

    Innovations in diagnostic technologies are significantly shaping the Global Autoimmune Disease Diagnostics Market Industry. The advent of advanced imaging techniques, biomarker identification, and genetic testing has enhanced the accuracy and speed of autoimmune disease diagnosis. For example, the use of multiplex assays allows for the simultaneous detection of multiple autoantibodies, improving diagnostic efficiency. These advancements not only facilitate early detection but also contribute to better patient outcomes. With the market expected to grow at a CAGR of 5.65% from 2025 to 2035, the integration of cutting-edge technologies is likely to play a crucial role in meeting the rising demand for effective diagnostic solutions.

    Market Segment Insights

    Autoimmune Disease Diagnostics Market Test Type Insights

    <p>The Autoimmune Disease Diagnostics Market was segmented into various test types, reflecting a significant aspect of the industry.Among these, Serological Tests held the largest share, valued at 2.4 USD Billion in 2024 and expected to grow to 4.3 USD Billion by 2035, highlighting their importance in detecting autoimmune diseases through serum analysis. This method was crucial for diagnosing conditions such as <a href="https://www.marketresearchfuture.com/reports/rheumatoid-arthritis-market-1658">rheumatoid arthritis</a> and lupus, as it identified specific antibodies in the patient's bloodstream, driving the demand for these tests.</p>

    <p>Molecular Diagnostics also gained traction, with an anticipated valuation of 1.8 USD Billion in 2024, rising to 3.5 USD Billion by 2035. This segment employed advanced techniques like PCR and next-generation sequencing, allowing for precise diagnosis and the identification of genetic markers associated with autoimmune diseases, thereby showing potential for significant growth within the market.Imaging Tests, valued at 1.0 USD Billion in 2024 and expected to double to 2.0 USD Billion in 2035, played a vital role in assessing the severity and progression of autoimmune disorders, providing critical visual insights that complement laboratory results.</p>

    <p>Lastly, Biopsies accounted for a valuation of 1.52 USD Billion in 2024, projected to reach 2.5 USD Billion by 2035. This test type was essential for obtaining tissue samples, allowing for direct examination of affected areas, thus facilitating accurate diagnosis and treatment planning.The growth of these test types was driven by increased awareness of autoimmune diseases, advancements in diagnostic technologies, and a surge in healthcare spending globally.</p>

    <p>The demand for precise and early detection of these conditions significantly shaped the Autoimmune Disease Diagnostics Market, as these diagnostics ultimately led to better patient outcomes and tailored therapies, making continuous innovation and adaptation essential to meet the evolving needs of this vital healthcare sector.</p>

    Autoimmune Disease Diagnostics Market Disease Type Insights

    <p>The market showcases a broad range of disease types, with notable segments including Rheumatoid Arthritis, Lupus, Multiple Sclerosis, Type 1 Diabetes, and Thyroid Disorders. Rheumatoid Arthritis remains a prominent focus due to its widespread impact on mobility and overall quality of life.Lupus is also critical, often affecting young women disproportionately, creating a pressing need for effective diagnostic tools. Multiple Sclerosis diagnostics are gaining attention as they play a crucial role in early intervention, which can greatly affect disease progression.</p>

    <p>Type 1 Diabetes diagnostics are vital for immediate treatment, enabling better management of the disease from an early age. Additionally, Thyroid Disorders diagnostics are essential as they affect a significant portion of the global population, often going unnoticed until symptoms become severe.</p>

    <p>The Autoimmune Disease Diagnostics Market statistics indicate that the demand for advanced and rapid diagnostic solutions is rising, propelled by increased awareness and improved healthcare access, making this sector ripe with opportunities for innovation and growth in the coming years.</p>

    Autoimmune Disease Diagnostics Market End-user Insights

    <p>The Autoimmune Disease Diagnostics Market is experiencing significant growth, driven by a rising prevalence of autoimmune diseases and advancements in diagnostic technologies. Among the key End-users, hospitals play a crucial role as they provide critical diagnostic services and patient care, significantly contributing to market growth.</p>

    <p>Diagnostic laboratories, which specialize in conducting various tests, also hold a major stake in the market, offering precise diagnostics that are essential for effective disease management.Research institutes are increasingly important as they contribute to the development of innovative diagnostic modalities and methodologies, focusing on enhancing the accuracy and efficiency of autoimmune disease detection.</p>

    <p>The increasing investments in healthcare infrastructure and a surge in awareness about autoimmune conditions are further propelling the Autoimmune Disease Diagnostics Market revenue. With the ongoing advancements in technology, the segmentation and service offerings in this market are expected to expand, providing opportunities for improved patient outcomes globally.An emphasis on early diagnosis and continuous monitoring will enhance the value of these end-user segments, continuing to shape the landscape of the Autoimmune Disease Diagnostics Market.</p>

    Autoimmune Disease Diagnostics Market Product Type Insights

    <p>The Autoimmune Disease Diagnostics Market is poised for growth, reflecting the increasing demand for accurate and efficient diagnostics. The Product Type segmentation of this market includes important categories such as Reagents, Instrumentations, and Software, each playing a vital role in the diagnosis and management of autoimmune diseases.</p>

    <p>Reagents are essential for performing tests that detect various autoimmune conditions, driving the majority of the market as they facilitate diagnosis by providing necessary components for testing. Instrumentations are significant due to advancements in technology which allow for faster and more precise results, making them crucial in clinical settings.</p>

    <p>Additionally, Software is increasingly important as it aids in data management and analysis, streamlining workflow in laboratories and enhancing diagnostic accuracy. The market is benefitting from trends such as increased awareness of autoimmune diseases and advancements in technology, although challenges such as high costs and regulatory barriers remain.The Autoimmune Disease Diagnostics Market data reveals that these trends create opportunities for innovation in all product types, which could enhance diagnostics capabilities and market growth.</p>

    Get more detailed insights about Autoimmune Disease Diagnostics Market Research Report - Forecast till 2035

    Regional Insights

    The Autoimmune Disease Diagnostics Market was characterized by significant regional diversity, with North America leading the way, holding a market value of 2.67 USD Billion in 2024 and projected to grow to 4.78 USD Billion by 2035, largely due to advanced healthcare infrastructure and a high prevalence of autoimmune disorders.

    Europe followed with a 2024 valuation of 1.88 USD Billion and a 2035 projection of 3.36 USD Billion, driven by increased awareness and R&D investments in diagnostic technologies. South America, valued at 0.45 USD Billion in 2024 and expected to reach 0.81 USD Billion by 2035, gradually expanded, propelled by rising healthcare access and government initiatives.

    The Asia Pacific region, valued at 1.67 USD Billion in 2024 with an anticipated rise to 2.98 USD Billion by 2035, benefited from rapid urbanization and growing healthcare investments. Meanwhile, the Middle East and Africa segment, with a valuation of 0.55 USD Billion projected to increase to 1.08 USD Billion, reflected the improving healthcare environment and investments in diagnostics.

    Together, these regional dynamics contributed to the overall growth and trends of the Autoimmune Disease Diagnostics Market, with varying degrees of market strength and development opportunities underpinning the different areas.

    Autoimmune Disease Diagnostics Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Autoimmune Disease Diagnostics Market is characterized by intense competition and a rapidly evolving landscape, driven by the increasing prevalence of autoimmune diseases and the growing demand for accurate diagnostic solutions.This market features a diverse range of players including established corporations, specialized biotech firms, and innovative start-ups that are engaged in developing advanced diagnostic tests and technologies.

    Competitive dynamics are influenced by factors such as technological advancement, regulatory changes, strategic collaborations, and the need for cost-effective solutions. Companies are striving to enhance their product offerings while also expanding their global reach through mergers, acquisitions, and partnerships that allow them to leverage synergies and shared expertise.

    1. HoffmannLa Roche holds a significant position in the Autoimmune Disease Diagnostics Market, leveraging its reputation for high-quality and reliable diagnostic solutions. With a well-established presence across multiple regions, the company benefits from a broad portfolio of diagnostic assays and instruments that cater to various autoimmune conditions.

    The strengths of F. HoffmannLa Roche lie in its robust research and development capabilities, allowing it to continually innovate and develop new diagnostic tests that are critical for early and accurate disease detection.The company’s commitment to quality and comprehensive customer support enhances its competitive advantage, enabling healthcare professionals to rely on its products when diagnosing autoimmune diseases.

    1. Menarini Diagnostics has carved a niche for itself within the Autoimmune Disease Diagnostics Market through a dedicated focus on diagnostic accuracy and reliability. The company offers a range of key products and services that are specifically designed to meet the needs of healthcare providers in diagnosing autoimmune conditions.

    Notably, A. Menarini Diagnostics has established a strong market presence by leveraging advanced technology to develop innovative diagnostic solutions that facilitate timely interventions. The strengths of the company include its agile approach to the market, allowing it to quickly adapt to emerging trends and shifting customer requirements.

    1. Menarini Diagnostics has also engaged in strategic mergers and acquisitions that bolster its product range and expand its reach, reinforcing its competitive positioning globally while ensuring compliance with regional regulations and quality standards.

    Key Companies in the Autoimmune Disease Diagnostics Market market include

    Industry Developments

    The worldwide market for autoimmune disease diagnostics experienced a number of noteworthy developments and calculated actions from market players at the beginning of 2025. Sanofi said on March 20, 2025, that it will buy Dren Bio's immunology division, namely the DR-0201 autoimmune treatment candidate, for $600 million up front and up to $1.3 billion in milestone payments.

    The agreement is anticipated to completion in Q2 2025. April 21, 2025: Immunovant, a subsidiary of Roivant Sciences, named Eric Venker as CEO and Tiago Girao as CFO. The company also focused on cutaneous lupus erythematosus and Sjögren's illness with its main diagnostic medication IMVT-1402, beginning proof-of-concept and registrational studies, respectively.

    An important advancement in diagnostic-linked biologics was made in April 2025 when the FDA authorized nipocalimab (Imaavy), an FcRn blocker for generalized myasthenia gravis. Argenx strengthened its diagnostic and therapeutic integration approach in May 2025 when it got FDA clearance for Vyvgart Hytrulo at-home therapy and an EMA good opinion for subcutaneous Vyvgart.

    In terms of product innovation, Progentec Diagnostics published CareMGMTTM, an app that helps patients monitor autoimmune diseases, in August 2024, while Predicta Biosciences introduced its first molecular diagnosis for multiple myeloma in June 2025.

    To improve lab diagnosis, Thermo Fisher released an Autoimmune Assay Kit in May 2023, and EUROIMMUN launched an automated IIFT system (UNIQO 160) in mid-2023 (June 2023) as well. In May 2025, inverse vaccines—a new immunotolerance diagnostic-therapeutic strategy—also began clinical trials for conditions including MS and celiac disease, thanks to collaborations between Genentech and AbbVie.

    Future Outlook

    Autoimmune Disease Diagnostics Market Future Outlook

    <p>The Autoimmune Disease Diagnostics Market is projected to grow at a 6.72% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of autoimmune diseases, and rising awareness.</p>

    New opportunities lie in:

    • <p>Develop AI-driven diagnostic tools for early detection of autoimmune diseases. Expand telehealth services for remote autoimmune disease management. Invest in personalized medicine approaches to enhance treatment efficacy.</p>

    <p>By 2035, the market is expected to be robust, reflecting significant advancements and increased accessibility.</p>

    Market Segmentation

    Autoimmune Disease Diagnostics Market End-user Outlook

    • Hospitals
    • Diagnostic Laboratories
    • Research Institutes

    Autoimmune Disease Diagnostics Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Autoimmune Disease Diagnostics Market Test Type Outlook

    • Serological Tests
    • Molecular Diagnostics
    • Imaging Tests
    • Biopsies

    Autoimmune Disease Diagnostics Market Disease Type Outlook

    • Rheumatoid Arthritis
    • Lupus
    • Multiple Sclerosis
    • Type 1 Diabetes
    • Thyroid Disorders

    Autoimmune Disease Diagnostics Market Product Type Outlook

    • Reagents
    • Instrumentations
    • Software

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024 6.72(USD Billion)
    Market Size 2035 11.41 (USD Billion)
    Compound Annual Growth Rate (CAGR) 6.72% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019 - 2024
    Market Forecast Units USD Billion
    Key Companies Profiled F. HoffmannLa Roche, A. Menarini Diagnostics, Genova Diagnostics, Novartis, BioRad Laboratories, Quest Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, Roche Diagnostics, Hologic, Danaher Corporation, AbbVie, Ortho Clinical Diagnostics, Abbott Laboratories, Merck KGaA
    Segments Covered Test Type, Disease Type, End-user, Product Type, Regional
    Key Market Opportunities Rising prevalence of autoimmune diseases, Advancements in diagnostic technologies, Increased awareness and education, Growth in personalized medicine, Expansion in point-of-care testing
    Key Market Dynamics Rising autoimmune disease prevalence, Advancements in diagnostic technologies, Increasing awareness and education, Growing demand for early diagnosis, Expansion of healthcare infrastructure
    Countries Covered North America, Europe, APAC, South America, MEA
    Market Size 2025 5.96 (USD Billion)

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected market size of the Autoimmune Disease Diagnostics Market by 2035?

    By 2035, the Autoimmune Disease Diagnostics Market is expected to reach a value of 12.3 USD Billion.

    What is the expected Compound Annual Growth Rate (CAGR) for the Autoimmune Disease Diagnostics Market from 2025 to 2035?

    The expected CAGR for the Autoimmune Disease Diagnostics Market from 2025 to 2035 is 5.65%.

    Which region dominated the Autoimmune Disease Diagnostics Market in 2024?

    In 2024, North America dominated the Autoimmune Disease Diagnostics Market with a value of 2.67 USD Billion.

    What is the anticipated market value for Serological Tests in the Autoimmune Disease Diagnostics Market by 2035?

    The market value for Serological Tests is anticipated to reach 4.3 USD Billion by 2035.

    Who are the major players in the Autoimmune Disease Diagnostics Market?

    Key players in the market include F. Hoffmann-La Roche, A. Menarini Diagnostics, Genova Diagnostics, and Novartis.

    What was the market value for Molecular Diagnostics in 2024?

    The market value for Molecular Diagnostics in 2024 was 1.8 USD Billion.

    How much is the Autoimmune Disease Diagnostics Market expected to grow in the Asia Pacific region by 2035?

    The Asia Pacific region is expected to grow to a market value of 2.98 USD Billion by 2035.

    What was the projected market value for Imaging Tests in the Autoimmune Disease Diagnostics Market by 2024?

    The market value for Imaging Tests by 2024 was 1.0 USD Billion.

    What challenges does the Autoimmune Disease Diagnostics Market currently face?

    The market faces challenges including high costs of diagnostic tests and the complexity of autoimmune diseases.

    What will be the market size for Biopsies by 2035 in the Autoimmune Disease Diagnostics Market?

    By 2035, the market size for Biopsies is expected to reach 2.5 USD Billion.

    1. --- "
    2. Table of Contents
    3. EXECUTIVE SUMMARY
    4. Market Overview
    5. Key Findings
    6. Market Segmentation
    7. Competitive Landscape
    8. Challenges and Opportunities
    9. Future Outlook
    10. MARKET INTRODUCTION
    11. Definition
    12. Scope of the study
    13. Research Objective
    14. Assumption
    15. Limitations
    16. RESEARCH METHODOLOGY
    17. Overview
    18. Data Mining
    19. Secondary Research
    20. Primary Research
    21. Primary Interviews and Information Gathering Process
    22. Breakdown of Primary Respondents
    23. Forecasting Model
    24. Market Size Estimation
    25. Bottom-Up Approach
    26. Top-Down Approach
    27. Data Triangulation
    28. Validation
    29. MARKET DYNAMICS
    30. Overview
    31. Drivers
    32. Restraints
    33. Opportunities
    34. MARKET FACTOR ANALYSIS
    35. Value chain Analysis
    36. Porter's Five Forces Analysis
    37. Bargaining Power of Suppliers
    38. Bargaining Power of Buyers
    39. Threat of New Entrants
    40. Threat of Substitutes
    41. Intensity of Rivalry
    42. COVID-19 Impact Analysis
    43. Market Impact Analysis
    44. Regional Impact
    45. Opportunity and Threat Analysis
    46. Autoimmune Disease Diagnostics Market, BY Test Type (USD Billion)
    47. Serological Tests
    48. Molecular Diagnostics
    49. Imaging Tests
    50. Biopsies
    51. Autoimmune Disease Diagnostics Market, BY Disease Type (USD Billion)
    52. Rheumatoid Arthritis
    53. Lupus
    54. Multiple Sclerosis
    55. Type 1 Diabetes
    56. Thyroid Disorders
    57. Autoimmune Disease Diagnostics Market, BY End User (USD Billion)
    58. Hospitals
    59. Diagnostic Laboratories
    60. Research Institutes
    61. Autoimmune Disease Diagnostics Market, BY Product Type (USD Billion)
    62. Reagents
    63. Instrumentations
    64. Software
    65. Autoimmune Disease Diagnostics Market, BY Regional (USD Billion)
    66. North America
    67. US
    68. Canada
    69. Europe
    70. Germany
    71. UK
    72. France
    73. Russia
    74. Italy
    75. Spain
    76. Rest of Europe
    77. APAC
    78. China
    79. India
    80. Japan
    81. South Korea
    82. Malaysia
    83. Thailand
    84. Indonesia
    85. Rest of APAC
    86. South America
    87. Brazil
    88. Mexico
    89. Argentina
    90. Rest of South America
    91. MEA
    92. GCC Countries
    93. South Africa
    94. Rest of MEA
    95. Competitive Landscape
    96. Overview
    97. Competitive Analysis
    98. Market share Analysis
    99. Major Growth Strategy in the Autoimmune Disease Diagnostics Market
    100. Competitive Benchmarking
    101. Leading Players in Terms of Number of Developments in the Autoimmune Disease Diagnostics Market
    102. Key developments and growth strategies
    103. New Product Launch/Service Deployment
    104. Merger & Acquisitions
    105. Joint Ventures
    106. Major Players Financial Matrix
    107. Sales and Operating Income
    108. Major Players R&D Expenditure. 2023
    109. Company Profiles
    110. Genentech
    111. Financial Overview
    112. Products Offered
    113. Key Developments
    114. SWOT Analysis
    115. Key Strategies
    116. Abbott Laboratories
    117. Financial Overview
    118. Products Offered
    119. Key Developments
    120. SWOT Analysis
    121. Key Strategies
    122. Hologic
    123. Financial Overview
    124. Products Offered
    125. Key Developments
    126. SWOT Analysis
    127. Key Strategies
    128. BD
    129. Financial Overview
    130. Products Offered
    131. Key Developments
    132. SWOT Analysis
    133. Key Strategies
    134. Quest Diagnostics
    135. Financial Overview
    136. Products Offered
    137. Key Developments
    138. SWOT Analysis
    139. Key Strategies
    140. Thermo Fisher Scientific
    141. Financial Overview
    142. Products Offered
    143. Key Developments
    144. SWOT Analysis
    145. Key Strategies
    146. ImmunoPrecise Antibodies
    147. Financial Overview
    148. Products Offered
    149. Key Developments
    150. SWOT Analysis
    151. Key Strategies
    152. ArcherDX
    153. Financial Overview
    154. Products Offered
    155. Key Developments
    156. SWOT Analysis
    157. Key Strategies
    158. LabCorp
    159. Financial Overview
    160. Products Offered
    161. Key Developments
    162. SWOT Analysis
    163. Key Strategies
    164. Roche Diagnostics
    165. Financial Overview
    166. Products Offered
    167. Key Developments
    168. SWOT Analysis
    169. Key Strategies
    170. Mayo Clinic Laboratories
    171. Financial Overview
    172. Products Offered
    173. Key Developments
    174. SWOT Analysis
    175. Key Strategies
    176. Eurofins Scientific
    177. Financial Overview
    178. Products Offered
    179. Key Developments
    180. SWOT Analysis
    181. Key Strategies
    182. BioRad Laboratories
    183. Financial Overview
    184. Products Offered
    185. Key Developments
    186. SWOT Analysis
    187. Key Strategies
    188. Cepheid
    189. Financial Overview
    190. Products Offered
    191. Key Developments
    192. SWOT Analysis
    193. Key Strategies
    194. Siemens Healthineers
    195. Financial Overview
    196. Products Offered
    197. Key Developments
    198. SWOT Analysis
    199. Key Strategies
    200. Appendix
    201. References
    202. Related Reports

    Autoimmune Disease Diagnostics Market Segmentation

    Autoimmune Disease Diagnostics Market By Test Type (USD Billion, 2019-2035)

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    Autoimmune Disease Diagnostics Market By Disease Type (USD Billion, 2019-2035)

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    Autoimmune Disease Diagnostics Market By End User (USD Billion, 2019-2035)

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    Autoimmune Disease Diagnostics Market By Product Type (USD Billion, 2019-2035)

    Reagents

    Instrumentations

    Software

    Autoimmune Disease Diagnostics Market By Regional (USD Billion, 2019-2035)

    North America

    Europe

    South America

    Asia Pacific

    Middle East and Africa

    Autoimmune Disease Diagnostics Market Regional Outlook (USD Billion, 2019-2035)

    North America Outlook (USD Billion, 2019-2035)

    North America Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    North America Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    North America Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    North America Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    North America Autoimmune Disease Diagnostics Market by Regional Type

    US

    Canada

    US Outlook (USD Billion, 2019-2035)

    US Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    US Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    US Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    US Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    CANADA Outlook (USD Billion, 2019-2035)

    CANADA Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    CANADA Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    CANADA Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    CANADA Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    Europe Outlook (USD Billion, 2019-2035)

    Europe Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    Europe Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    Europe Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    Europe Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    Europe Autoimmune Disease Diagnostics Market by Regional Type

    Germany

    UK

    France

    Russia

    Italy

    Spain

    Rest of Europe

    GERMANY Outlook (USD Billion, 2019-2035)

    GERMANY Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    GERMANY Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    GERMANY Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    GERMANY Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    UK Outlook (USD Billion, 2019-2035)

    UK Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    UK Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    UK Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    UK Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    FRANCE Outlook (USD Billion, 2019-2035)

    FRANCE Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    FRANCE Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    FRANCE Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    FRANCE Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    RUSSIA Outlook (USD Billion, 2019-2035)

    RUSSIA Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    RUSSIA Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    RUSSIA Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    RUSSIA Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    ITALY Outlook (USD Billion, 2019-2035)

    ITALY Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    ITALY Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    ITALY Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    ITALY Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    SPAIN Outlook (USD Billion, 2019-2035)

    SPAIN Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    SPAIN Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    SPAIN Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    SPAIN Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    REST OF EUROPE Outlook (USD Billion, 2019-2035)

    REST OF EUROPE Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    REST OF EUROPE Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    REST OF EUROPE Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    REST OF EUROPE Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    APAC Outlook (USD Billion, 2019-2035)

    APAC Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    APAC Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    APAC Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    APAC Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    APAC Autoimmune Disease Diagnostics Market by Regional Type

    China

    India

    Japan

    South Korea

    Malaysia

    Thailand

    Indonesia

    Rest of APAC

    CHINA Outlook (USD Billion, 2019-2035)

    CHINA Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    CHINA Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    CHINA Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    CHINA Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    INDIA Outlook (USD Billion, 2019-2035)

    INDIA Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    INDIA Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    INDIA Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    INDIA Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    JAPAN Outlook (USD Billion, 2019-2035)

    JAPAN Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    JAPAN Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    JAPAN Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    JAPAN Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    SOUTH KOREA Outlook (USD Billion, 2019-2035)

    SOUTH KOREA Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    SOUTH KOREA Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    SOUTH KOREA Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    SOUTH KOREA Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    MALAYSIA Outlook (USD Billion, 2019-2035)

    MALAYSIA Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    MALAYSIA Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    MALAYSIA Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    MALAYSIA Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    THAILAND Outlook (USD Billion, 2019-2035)

    THAILAND Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    THAILAND Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    THAILAND Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    THAILAND Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    INDONESIA Outlook (USD Billion, 2019-2035)

    INDONESIA Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    INDONESIA Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    INDONESIA Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    INDONESIA Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    REST OF APAC Outlook (USD Billion, 2019-2035)

    REST OF APAC Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    REST OF APAC Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    REST OF APAC Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    REST OF APAC Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    South America Outlook (USD Billion, 2019-2035)

    South America Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    South America Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    South America Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    South America Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    South America Autoimmune Disease Diagnostics Market by Regional Type

    Brazil

    Mexico

    Argentina

    Rest of South America

    BRAZIL Outlook (USD Billion, 2019-2035)

    BRAZIL Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    BRAZIL Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    BRAZIL Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    BRAZIL Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    MEXICO Outlook (USD Billion, 2019-2035)

    MEXICO Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    MEXICO Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    MEXICO Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    MEXICO Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    ARGENTINA Outlook (USD Billion, 2019-2035)

    ARGENTINA Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    ARGENTINA Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    ARGENTINA Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    ARGENTINA Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

    REST OF SOUTH AMERICA Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    REST OF SOUTH AMERICA Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    REST OF SOUTH AMERICA Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    REST OF SOUTH AMERICA Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    MEA Outlook (USD Billion, 2019-2035)

    MEA Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    MEA Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    MEA Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    MEA Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    MEA Autoimmune Disease Diagnostics Market by Regional Type

    GCC Countries

    South Africa

    Rest of MEA

    GCC COUNTRIES Outlook (USD Billion, 2019-2035)

    GCC COUNTRIES Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    GCC COUNTRIES Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    GCC COUNTRIES Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    GCC COUNTRIES Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    SOUTH AFRICA Outlook (USD Billion, 2019-2035)

    SOUTH AFRICA Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    SOUTH AFRICA Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    SOUTH AFRICA Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    SOUTH AFRICA Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

    REST OF MEA Outlook (USD Billion, 2019-2035)

    REST OF MEA Autoimmune Disease Diagnostics Market by Test Type

    Serological Tests

    Molecular Diagnostics

    Imaging Tests

    Biopsies

    REST OF MEA Autoimmune Disease Diagnostics Market by Disease Type

    Rheumatoid Arthritis

    Lupus

    Multiple Sclerosis

    Type 1 Diabetes

    Thyroid Disorders

    REST OF MEA Autoimmune Disease Diagnostics Market by End User Type

    Hospitals

    Diagnostic Laboratories

    Research Institutes

    REST OF MEA Autoimmune Disease Diagnostics Market by Product Type

    Reagents

    Instrumentations

    Software

     

     

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027